Testing effectiveness (Phase 2)WithdrawnNCT04107961
What this trial is testing
Assess Safety and Efficacy of a Leishmania Vaccine to Prevent Post Kala Azar Dermal Leishmaniasis (PKDL)
Who this might be right for
Post-kala-azar Dermal Leishmaniasis
University of York